Investor Alert

New York Markets Close in:

Revolution Medicines Inc.



Market open

 --Real time quotes

Nov 30, 2023, 1:02 p.m.





+0.64 +2.85%


Volume 504,039

Real time quotes


Previous close

$ 22.46

$ 23.10


+0.64 +2.85%

Day low

Day high




52 week low

52 week high




Flavia Borellini

Flavia Borellini is on the board of Cantargia AB, Revolution Medicines, Inc., Kartos Therapeutics, Inc. and Viracta Therapeutics, Inc. and Member of Roche Group.

In the past Dr. Borellini was VP-Global Product & Portfolio Strategy at AstraZeneca PLC and Chief Executive Officer for Acerta Pharma BV (a subsidiary of AstraZeneca PLC) and Vice President-Program Leadership at Onyx Pharmaceuticals, Inc.

Dr. Borellini received a doctorate from Universit? degli Studi di Modena e Reggio Emilia.


Date Shares Transaction Value
06/08/2023 5,200   Award at $0 per share. 0
06/16/2022 5,200   Award at $0 per share. 0
06/22/2021 7,234   Award at $0 per share. 0

Officers and Executives

Dr. Mark A. Goldsmith
Chairman, President & Chief Executive Officer
Dr. Margaret A. Horn
Chief Operating Officer
Mr. Jack Anders
Chief Financial Officer
Dr. Stephen M. Kelsey
President-Research & Development
Dr. Walter Reiher
Chief Information Officer
Dr. Xiao Lin Wang
Executive Vice President-Clinical Development
Mr. Daniel Simon
Chief Business Officer
Ms. Linnet Zia
VP-Strategy, Financial Planning & Analysis
Ms. Luan M. Wilfong
Chief Human Resources Officer
Mr. Jeff Cislini
Secretary, Senior Vice President & General Counsel
Dr. Flavia Borellini
Independent Director
Dr. Sushil Patel
Independent Director
Dr. Lorence H. Kim
Independent Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth McKee Anderson
Independent Director
Mr. Alexis A. Borisy
Lead Independent Director
Dr. Thilo Schroeder
Independent Director
Dr. Barbara L. Weber
Independent Director
Link to MarketWatch's Slice.